Propranolol Attenuates Proangiogenic Activity of Mononuclear Phagocytes: Implication in Choroidal Neovascularization-Reference-Cited by-同舟云学术

Propranolol Attenuates Proangiogenic Activity of Mononuclear Phagocytes: Implication in Choroidal Neovascularization

Published:2019-11-04 Issue:14 Volume:60 Page:4632
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Omri Samy¹,Tahiri Houda²,Pierre Wyston Chadwick³,Desjarlais Michel²,Lahaie Isabelle¹,Loiselle Sarah-Eve⁴,Rezende Flavio¹,Lodygensky Gregory⁵,Hebert Terence E.⁶,Ong Huy⁷,Chemtob Sylvain¹⁸⁹¹⁰

Affiliation:

1. Department of Ophthalmology, Maisonneuve-Rosemont Hospital Research Center, Université de Montréal, Montreal, Quebec, Canada

2. Department of Pharmacology, Maisonneuve-Rosemont Hospital Research Center, Université de Montréal, Montreal, Quebec, Canada

3. Department of Pharmacology, Sainte-Justine Hospital Research Center, Université de Montréal, Montreal, Quebec, Canada

4. Department of Biomedical Sciences, Sainte-Justine Hospital Research Center, Université de Montréal, Montreal, Quebec, Canada

5. Department of Pediatrics, Faculty of Medicine, Sainte-Justine Hospital Research Center, Université de Montréal, Montreal, Quebec, Canada

6. Department of Pharmacology & Therapeutics, McGill University, Montreal, Quebec, Canada

7. Faculty of Pharmacy, Université de Montréal, Montreal, Canada

8. Department of Pediatrics, Université de Montréal, Montreal, Canada

9. Department of Ophthalmology, Université de Montréal, Montreal, Canada

10. Department of Pharmacology, Université de Montréal, Montreal, Canada

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geographic characterization of RPE structure and lipid changes in the PEX1-p.Gly844Asp mouse model for Zellweger spectrum disorder;2024-09-10

2. Polymeric Propranolol Nanoparticles for Intraocular Delivery: Formulation, Characterization, and Vitreous Pharmacokinetics;Journal of Ophthalmic and Vision Research;2024-03-10

3. BHTCM Protects Müller Cells from Diabetic Retinopathy by Reducing Abnormal Changes of Kir4.1 and AQP4, Suppressing VEGF and IL-1β, and Enhancing PEDF Production;Letters in Drug Design & Discovery;2023-08

4. β-Adrenoreceptors as Therapeutic Targets for Ocular Tumors and Other Eye Diseases—Historical Aspects and Nowadays Understanding;International Journal of Molecular Sciences;2023-02-28

5. Propranolol Therapy for Congenital Chylothorax;Pediatrics;2023-01-18